Location History:
- Berchem, BE (2010 - 2014)
- Beerse, BE (2019 - 2021)
- Edegem, BE (2014 - 2024)
Company Filing History:
12 out of 111 
9 out of 2,078 
8 out of 60 
Years Active: 2010-2024
Title: Anil Koul: A Pioneer in Pharmaceutical Innovations
Introduction
Anil Koul is a distinguished inventor based in Edegem, Belgium, known for his impactful contributions to the pharmaceutical industry. With an impressive portfolio of 31 patents, Koul has made significant strides in developing innovative treatments for various health conditions, notably tuberculosis and respiratory syncytial virus (RSV) infections.
Latest Patents
Among Koul's latest patents are groundbreaking inventions that focus on combination therapies. One notable patent involves a combination treatment utilizing PZA and a cytochrome Bc1 inhibitor, aimed at effectively treating tuberculosis. Additionally, his patent for treating RSV infection details a combination product comprising two specific compounds. The first, Compound A, is identified by its complex chemical structure, which includes elements such as 5-chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl and 1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one. The second, Compound B, features a unique composition designed to enhance viral inhibition. This combination product underscores Koul’s innovative approach to tackling viral infections through targeted therapies.
Career Highlights
Throughout his career, Anil Koul has made significant contributions to leading companies in the pharmaceutical sector. He has worked with Janssen Sciences Ireland and Janssen Pharmaceutica, both renowned for their advancements in medical research and drug development. His expertise and innovative mindset have positioned him as a key player in the field, leading to numerous successful patent applications.
Collaborations
Koul has collaborated with several notable professionals, enhancing his research and development efforts. His coworkers include David Francis, Alain Lançois, and Magali Madeleine Simone Motte, who have contributed to the success of various projects through their expertise and dedication. These collaborations reflect the importance of teamwork in advancing the frontier of pharmaceutical innovations.
Conclusion
Anil Koul's contributions to the field of pharmaceuticals through his innovative inventions and patents demonstrate his commitment to improving healthcare solutions. With each new patent, he continues to pave the way for cutting-edge treatments that address pressing medical issues, reaffirming his status as a leader in pharmaceutical innovation.